TARA Protara Therapeutics, Inc. - Common Stock
Protara Therapeutics, Inc. - Common Stock के बारे में विकिपीडिया से कंपनी का अवलोकन
Proteon Therapeutics, Inc. is a developer of pharmaceuticals with offices in Waltham, Massachusetts and Kansas City, Missouri.
और पढ़ें
Proteon Therapeutics, Inc. is a developer of pharmaceuticals with offices in Waltham, Massachusetts and Kansas City, Missouri.
Company History
Proteon was founded by Dr. F. Nicholas Franano based on technology created at Johns Hopkins University. Major investors in the company include MPM Capital, Rockhill Partners, TVM Capital, Skyline Ventures, Prism VentureWorks, Vectis Life Sciences and Intersouth Partners. They have invested over $72 million in the company.
The company is led by Timothy Noyes, CEO; Steven Burke, CMO; George Eldridge, CFO; and Scott Toner, director of marketing.
On March 5, 2009, the company announced that it had raised $32 million from its existing investors plus MPM Capital and Vectis Life Sciences. Proteon also announced that it had entered into an option agreement to be acquired by Novartis for up to $550 million. The company went public in 2014.
In September 2019, Proteon Therapeutics merged with ArTara Therapeutics.
PRT-201
Proteon is developing PRT-201 (vonapanitase), a drug to improve blood flow following vascular surgery procedures, and, more broadly, is interested in vascular access for hemodialysis and peripheral arterial disease (PAD). PRT-201 is a recombinant human elastase manufactured for Proteon by Lonza.
In September 2008, the company announced that the Food and Drug Administration had granted fast track status to PRT-201.
In December 2016, they announced that the phase III trial of PRT-201 hadn't reached its primary endpoint, causing Proteon's stock price to drop more than 75%.
स्रोत: विकिपीडिया (अंग्रेज़ी), CC BY-SA 4.0 · विकिपीडिया पर देखें ↗
TARA स्टॉक स्नैपशॉट मूल्य, बाजार पूंजीकरण, P/E, EPS, ROE, ऋण/इक्विटी, 52-सप्ताह की सीमा
TARA स्टॉक मूल्य चार्ट तकनीकी संकेतकों के साथ दैनिक OHLCV — पैन, ज़ूम और अपना दृश्य कस्टमाइज़ करें
10-वर्षीय प्रदर्शन राजस्व, शुद्ध आय, मार्जिन और ईपीएस रुझान
मूल्यांकन P/E, P/S, P/B, EV/EBITDA अनुपात — क्या स्टॉक महंगा है या सस्ता?
लाभप्रदता सकल, परिचालन और शुद्ध मार्जिन; ROE, ROA, ROIC
वित्तीय स्वास्थ्य ऋण, तरलता, शोधन क्षमता — बैलेंस शीट की मजबूती
विकास राजस्व, EPS और शुद्ध आय वृद्धि: YoY, 3Y CAGR, 5Y CAGR
पूंजी दक्षता एसेट टर्नओवर, इन्वेंटरी टर्नओवर, प्राप्य टर्नओवर
TARA विश्लेषक सर्वसम्मति तेजी और मंदी के विश्लेषक राय, 12-महीने का मूल्य लक्ष्य, अपसाइड
- मजबूत खरीद 3 21.4%
- खरीदें 10 71.4%
- होल्ड 1 7.1%
- बेचें 0 0.0%
- मजबूत बिक्री 0 0.0%
12-महीने का मूल्य लक्ष्य
7 विश्लेषक · 2026-08-13Earnings History EPS वास्तविक बनाम अनुमान, आश्चर्य %, बीट दर, अगली आय तिथि
| Period | EPS Actual | EPS अनुमान | आश्चर्य |
|---|---|---|---|
| 31 मार्च 2026 | $-0.31 | $-0.38 | 0.07% |
| 31 दिसमबर 2025 | $-0.37 | $-0.33 | -0.04% |
| 30 सितमबर 2025 | $-0.31 | $-0.39 | 0.08% |
| 30 जून 2025 | $-0.35 | $-0.41 | 0.06% |
| 31 मार्च 2025 | $-0.29 | $-0.46 | 0.17% |
सहकर्मी तुलना (GICS उप-उद्योग) प्रमुख मेट्रिक्स बनाम सेक्टर के साथी
| टिकर | मार्केट कैप | P/E | राजस्व YoY | शुद्ध मार्जिन | ROE | सकल मार्जिन |
|---|---|---|---|---|---|---|
| TARA | $286M | -4.0 | — | — | -33.7% | — |
| CNXU | — | — | — | — | — | — |
| GLSI | $300M | -14.7 | — | — | -2159.7% | — |
| PYXS | $72M | -0.9 | -14.2% | -574.5% | -112.9% | — |
| RCEL | $105M | -2.0 | 11.5% | -67.8% | 328.9% | 82.1% |
| AKBA | $427M | -80.5 | 47.5% | -2.3% | -17.3% | — |
| ALEC | $172M | -1.1 | -79.1% | -679.2% | -280.7% | — |
| EBS | $644M | 13.3 | -28.8% | 7.1% | 9.9% | — |
| ARCT | $174M | -2.6 | -46.1% | -80.2% | -29.6% | — |
| NBP | — | — | — | — | — | — |
पूर्ण मौलिक सभी मेट्रिक्स प्रति वर्ष — आय विवरण, बैलेंस शीट, नकदी प्रवाह
आय विवरण 16
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | · | · | $3M | |
| R&D Expense | $43M | $32M | $25M | $17M | $21M | $12M | $4M | $12M | $22M | $19M | $12M | $6M | |
| SG&A Expense | $22M | $17M | $19M | $21M | $26M | $22M | $4M | $10M | $9M | $10M | $8M | $4M | |
| Operating Expenses | $65M | $49M | $44M | $67M | $47M | $34M | $8M | $21M | $30M | $29M | $21M | $11M | |
| Operating Income | $-65M | $-49M | $-44M | $-67M | $-47M | $-34M | $-8M | $-21M | $-30M | $-29M | $-21M | $-8M | |
| Interest Expense | · | · | · | · | $0 | $34.0K | · | · | · | · | · | $857.0K | |
| Interest Income | $6M | $4M | $3M | $1M | $237.0K | $500.0K | · | · | · | · | · | · | |
| Other Non-op | $7M | $5M | $3M | $1M | $237.0K | $466.0K | · | $207.0K | $139.0K | $-14.0K | $-651.0K | $5M | |
| Pretax Income | $57M | $45M | · | · | · | · | $-15M | $-21M | $-30M | $-29M | $-21M | $-3M | |
| Income Tax | · | · | · | · | · | · | · | · | · | · | · | $-110.0K | |
| Net Income | $-57M | $-45M | $-40M | $-66M | $-47M | $-34M | $-8M | $-21M | $-30M | $-29M | $-21M | $-3M | |
| EPS (Basic) | $-1.34 | $-2.17 | $-3.57 | $-5.86 | $-4.21 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-1.34 | $-2.17 | $-3.57 | $-5.86 | $-4.21 | · | · | · | · | · | · | · | |
| Shares (Basic) | 42,836,129 | 20,592,847 | 11,331,338 | 11,259,615 | · | · | · | · | · | · | · | · | |
| Shares (Diluted) | 42,836,129 | 20,592,847 | 11,331,338 | 11,259,615 | 11,232,576 | · | · | · | · | · | · | · | |
| EBITDA | $-65M | $-49M | $-44M | $-67M | $-47M | $-34M | $-15M | · | · | $-29M | $-21M | $-8M |
बैलेंस शीट 23
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $50M | $163M | $40M | $24M | $36M | $169M | $564.0K | $19M | $21M | $36M | $40M | $69M | |
| Short-term Investments | $106M | $7M | $26M | $60M | $56M | · | · | $2M | $21M | $5M | $25M | $15M | |
| Prepaid Expense | $4M | $2M | $3M | $2M | $2M | $787.0K | $78.0K | $1M | $1M | $1M | $1M | $1M | |
| Other Current Assets | $65.0K | $2.0K | $37.0K | $127.0K | $34.0K | $52.0K | · | · | · | · | · | · | |
| Current Assets | $160M | $172M | $69M | $86M | $93M | $169M | $764.0K | $23M | $43M | $43M | $67M | $85M | |
| PP&E (Net) | $759.0K | $1M | $1M | $2M | $2M | $1M | $459.0K | $263.0K | $259.0K | $372.0K | $224.0K | $83.0K | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $1M | $475.0K | $1M | $971.0K | $937.0K | $665.0K | $467.0K | |
| Accum. Depreciation | $1M | $1M | $824.0K | $483.0K | $236.0K | $119.0K | $16.0K | $827.0K | $712.0K | $565.0K | $441.0K | $384.0K | |
| Goodwill | · | · | · | · | $30M | $30M | · | · | · | · | · | · | |
| Other Non-current Assets | $20.0K | $27.0K | $11.0K | $16.0K | $865.0K | $1M | · | · | $218.0K | $393.0K | $706.0K | $114.0K | |
| Total Assets | $209M | $181M | $79M | $113M | $173M | $203M | $1M | $24M | $44M | $44M | $68M | $85M | |
| Accounts Payable | $3M | $4M | $2M | $2M | $954.0K | $914.0K | $716.0K | $441.0K | $291.0K | $556.0K | $1M | $917.0K | |
| Accrued Liabilities | $6M | $5M | $3M | $3M | $2M | $2M | $3M | $3M | $9M | $5M | $3M | $1M | |
| Current Liabilities | $11M | $11M | $6M | $6M | $4M | $3M | $3M | $3M | $9M | $5M | $4M | $2M | |
| Capital Leases | $2M | $3M | $4M | $5M | $6M | $999.0K | · | · | · | · | · | · | |
| Total Liabilities | $13M | $14M | $11M | $11M | $11M | $4M | $3M | $3M | $9M | $5M | $4M | $2M | |
| Common Stock | $54.0K | $35.0K | $11.0K | $11.0K | $11.0K | $11.0K | $3.0K | · | $18.0K | $17.0K | $16.0K | $16.0K | |
| Paid-in Capital | $499M | $412M | $269M | $263M | $256M | $246M | $11M | $209M | $203M | $198M | $195M | $192M | |
| Retained Earnings | $-302M | $-245M | $-200M | $-160M | $-94M | $-47M | $-13M | $-210M | $-190M | $-160M | $-131M | $-110M | |
| AOCI | $90.0K | $2.0K | $-31.0K | $-688.0K | $-211.0K | · | $3.0K | $5.0K | $-14.0K | · | $-11.0K | $-6.0K | |
| Stockholders' Equity | $196M | $167M | $68M | $102M | $162M | $199M | $-2M | $5M | $35M | $38M | $63M | $82M | |
| Liabilities + Equity | $209M | $181M | $79M | $113M | $173M | $203M | $1M | $24M | $44M | $44M | $68M | $85M | |
| Shares Outstanding | 53,587,260 | 35,044,772 | 11,364,903 | 11,267,389 | 11,235,731 | 11,211,840 | 2,627,533 | 481,091 | 17,674,729 | 16,603,559 | 16,501,500 | 16,448,455 |
नकदी प्रवाह 14
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | $123.0K | $57.0K | $30.0K | |
| Stock-based Comp | $4M | $4M | $6M | $7M | $10M | $10M | $424.0K | $3M | $3M | $3M | $2M | $459.0K | |
| Deferred Tax | $-11M | $-20M | $-14M | $-9M | $-5M | $-9M | · | · | · | · | · | · | |
| Restructuring | · | · | · | · | · | · | $3M | · | · | · | · | · | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | $1M | $2M | $-7M | |
| Operating Cash Flow | $-56M | $-36M | $-38M | $-26M | $-35M | $-23M | $-5M | $-23M | $-22M | $-24M | $-18M | $-10M | |
| CapEx | $94.0K | $63.0K | $45.0K | $120.0K | $596.0K | $884.0K | $475.0K | $119.0K | $35.0K | $271.0K | $198.0K | $51.0K | |
| Investing Cash Flow | $-139M | $19M | $53M | $15M | $-98M | $3M | $-475.0K | $18M | $-16M | $20M | $-11M | · | |
| Stock Issued | · | · | · | · | · | $74M | · | · | · | · | · | $62M | |
| Stock Repurchased | · | · | $91.0K | $90.0K | $228.0K | · | · | · | · | · | · | · | |
| Net Stock Activity | · | · | $-91.0K | $-90.0K | $-228.0K | $66M | · | · | · | · | · | $62M | |
| Financing Cash Flow | $83M | $140M | $-91.0K | $-90.0K | $-228.0K | $189M | $500.0K | $3M | $23M | $208.0K | $163.0K | · | |
| Net Change in Cash | · | · | · | · | · | · | $-13M | $-2M | $-15M | $-4M | $-29M | $66M | |
| Free Cash Flow | $-56M | $-36M | $-38M | $-27M | $-35M | $-24M | $-16M | · | · | $-24M | $-18M | $-10M |
लाभप्रदता 5
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | -7391.4% | · | · | · | · | · | -257.1% | |
| Net Margin | · | · | · | · | · | -7291.4% | · | · | · | · | · | -113.4% | |
| EBITDA Margin | · | · | · | · | · | -7391.4% | · | · | · | · | · | -256.1% | |
| ROA | -29.4% | -34.2% | -42.0% | -46.1% | -25.1% | -33.2% | -98.3% | · | · | -51.4% | -28.1% | -7.4% | |
| ROE | -33.7% | -35.8% | -55.6% | -54.7% | -28.4% | -17.2% | -449.1% | · | · | -56.0% | -29.3% | 37.0% |
तरलता और शोधन क्षमता 3
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 14.6 | 15.7 | 11.2 | 15.0 | 21.7 | 58.1 | 12.0 | · | · | 8.4 | 16.1 | 36.2 | |
| Quick Ratio | 14.2 | 15.5 | 10.7 | 14.7 | 21.2 | 57.8 | 10.6 | · | · | 8.1 | 15.8 | 35.8 | |
| Interest Coverage | · | · | · | · | · | -1013.1 | · | · | · | · | · | -8.8 |
दक्षता 1
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | 0.0 | · | · | · | · | · | 0.1 |
मूल्यांकन (TTM) 10
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | · | · | · | · | · | $3M | |
| Net Income TTM | $-57M | $-45M | $-40M | $-66M | $-47M | $-34M | $-8M | $-21M | $-30M | $-29M | $-21M | $-3M | |
| Market Cap | $286M | $185M | $21M | $30M | $76M | $271M | $9M | · | · | $1.26B | $10.24B | $6.84B | |
| P/E | -4.0 | -2.4 | -0.5 | -0.5 | -1.6 | · | · | · | · | · | · | · | |
| P/S | · | · | · | · | · | · | · | · | · | · | · | 2321.1 | |
| P/B | 1.5 | 1.1 | 0.3 | 0.3 | 0.5 | 1.4 | 1.4 | · | · | 32.8 | 161.5 | 83.0 | |
| P / Tangible Book | 1.5 | 1.1 | 0.3 | 0.3 | 0.6 | 1.6 | · | · | · | · | · | · | |
| P / Cash Flow | -5.1 | -5.2 | -0.6 | -1.1 | -2.2 | -11.6 | -0.6 | · | · | -53.3 | -582.8 | -684.9 | |
| P / FCF | -5.1 | -5.2 | -0.6 | -1.1 | -2.2 | -11.2 | -0.6 | · | · | -52.7 | -576.3 | -681.5 | |
| Earnings Yield | -25.1% | -41.1% | -190.4% | -218.7% | -62.4% | · | · | · | · | · | · | · |
आय विवरण 12
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $17M | $14M | $13M | $10M | $11M | $9M | $9M | $8M | $6M | $8M | $6M | $6M | $7M | $5M | $5M | $3M | |
| SG&A Expense | $6M | $6M | $6M | $5M | $6M | $5M | $5M | $4M | $4M | $4M | $5M | $4M | $5M | $5M | $5M | $5M | |
| Operating Expenses | $23M | $20M | $19M | $15M | $17M | $14M | $14M | $12M | $11M | $12M | $11M | $11M | $12M | $10M | $40M | $8M | |
| Operating Income | $-23M | $-20M | $-19M | $-15M | $-17M | $-14M | $-14M | $-12M | $-11M | $-12M | $-11M | $-11M | $-12M | $-10M | $-40M | $-8M | |
| Interest Income | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $756.0K | $820.0K | $840.0K | $846.0K | $687.0K | $542.0K | $283.0K | |
| Other Non-op | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $756.0K | $820.0K | $840.0K | $846.0K | $687.0K | $542.0K | $283.0K | |
| Net Income | $-22M | $-18M | $-17M | $-13M | $-15M | $-12M | $-13M | $-11M | $-10M | $-11M | $-10M | $-10M | $-11M | $-9M | $-39M | $-8M | |
| EPS (Basic) | $-0.36 | $-0.31 | $-0.39 | $-0.31 | $-0.35 | $-0.29 | $-0.25 | $-0.50 | $-0.45 | $-0.97 | $-0.90 | $-0.87 | $-1.00 | $-0.80 | $-3.46 | $-0.68 | |
| EPS (Diluted) | $-0.36 | $-0.31 | $-0.39 | $-0.31 | $-0.35 | $-0.29 | $-0.25 | $-0.50 | $-0.45 | $-0.97 | $-0.90 | $-0.87 | $-1.00 | $-0.80 | $-3.46 | $-0.68 | |
| Shares (Basic) | 61,006,766 | 57,538,833 | -82,414,767 | 42,272,104 | 42,270,855 | 40,707,937 | -34,391,036 | 22,329,772 | 21,233,163 | 11,420,948 | -22,628,260 | 11,347,887 | 11,307,842 | 11,303,869 | -22,511,202 | 11,265,475 | |
| Shares (Diluted) | 61,006,766 | 57,538,833 | -82,414,767 | 42,272,104 | 42,270,855 | 40,707,937 | -34,391,036 | 22,329,772 | 21,233,163 | 11,420,948 | -22,628,260 | 11,347,887 | 11,307,842 | 11,303,869 | -22,511,202 | 11,265,475 | |
| EBITDA | $-23M | $-20M | · | $-15M | $-17M | $-14M | · | $-12M | $-11M | $-12M | · | $-11M | $-12M | $-10M | · | $-8M |
बैलेंस शीट 23
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $17M | $15M | $50M | $13M | $31M | $91M | $163M | $52M | $90M | $52M | $40M | $34M | $34M | $21M | $24M | $47M | |
| Short-term Investments | $125M | $121M | $106M | $120M | $91M | $33M | $7M | $30M | · | $3M | $26M | $40M | $46M | $66M | $60M | $49M | |
| Prepaid Expense | $4M | $4M | $4M | $3M | $3M | $2M | $2M | $4M | $3M | $3M | $3M | $4M | $4M | $8M | $2M | $2M | |
| Other Current Assets | $230.0K | $17.0K | $65.0K | $218.0K | $78.0K | $16.0K | $2.0K | $3.0K | $4.0K | $3.0K | $37.0K | $2.0K | $1.0K | $127.0K | $127.0K | · | |
| Current Assets | $146M | $140M | $160M | $136M | $125M | $127M | $172M | $85M | $92M | $58M | $69M | $78M | $84M | $95M | $86M | $99M | |
| PP&E (Net) | $1M | $669.0K | $759.0K | $828.0K | $912.0K | $988.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | |
| PP&E (Gross) | · | · | $2M | · | · | · | $2M | · | · | · | $2M | · | · | · | $2M | · | |
| Accum. Depreciation | · | · | $1M | · | · | · | $1M | · | · | · | $824.0K | · | · | · | $483.0K | · | |
| Goodwill | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $30M | |
| Other Non-current Assets | $74.0K | $76.0K | $20.0K | $21.0K | $29.0K | $35.0K | $27.0K | $33.0K | $19.0K | $31.0K | $11.0K | $3M | $3M | $586.0K | $16.0K | $734.0K | |
| Total Assets | $176M | $192M | $209M | $145M | $157M | $169M | $181M | $94M | $102M | $68M | $79M | $88M | $95M | $106M | $113M | $149M | |
| Accounts Payable | $5M | $4M | $3M | $5M | $5M | $2M | $4M | $2M | $1M | $972.0K | $2M | $3M | $2M | $4M | $2M | $456.0K | |
| Accrued Liabilities | $7M | $4M | $6M | $4M | $3M | $4M | $5M | $5M | $3M | $4M | $3M | $3M | $2M | $1M | $3M | $2M | |
| Current Liabilities | $13M | $9M | $11M | $10M | $10M | $7M | $11M | $9M | $6M | $6M | $6M | $7M | $5M | $6M | $6M | $4M | |
| Capital Leases | $1M | $2M | $2M | $2M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $6M | |
| Total Liabilities | $15M | $11M | $13M | $12M | $13M | $10M | $14M | $12M | $10M | $10M | $11M | $12M | $10M | $12M | $11M | $9M | |
| Common Stock | $59.0K | $55.0K | $54.0K | $39.0K | $39.0K | $39.0K | $35.0K | $21.0K | $21.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | |
| Paid-in Capital | $503M | $502M | $499M | $417M | $416M | $415M | $412M | $314M | $313M | $270M | $269M | $267M | $266M | $264M | $263M | $261M | |
| Retained Earnings | $-342M | $-320M | $-302M | $-285M | $-272M | $-257M | $-245M | $-232M | $-221M | $-211M | $-200M | $-190M | $-180M | $-169M | $-160M | $-121M | |
| AOCI | $-363.0K | $-364.0K | $90.0K | $143.0K | $77.0K | $89.0K | $2.0K | $29.0K | · | $-1.0K | $-31.0K | $-165.0K | $-336.0K | $-469.0K | $-688.0K | $-1M | |
| Stockholders' Equity | $161M | $181M | $196M | $132M | $144M | $158M | $167M | $82M | $92M | $58M | $68M | $77M | $85M | $95M | $102M | $139M | |
| Liabilities + Equity | $176M | $192M | $209M | $145M | $157M | $169M | $181M | $94M | $102M | $68M | $79M | $88M | $95M | $106M | $113M | $149M | |
| Shares Outstanding | 59,083,935 | 55,055,582 | 53,587,260 | 38,587,260 | 38,581,863 | 38,577,813 | 35,044,772 | 20,629,772 | 11,364,903 | 11,433,837 | 11,364,903 | 11,364,903 | 11,307,962 | 11,306,753 | 11,267,389 | 11,267,389 |
नकदी प्रवाह 8
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $1M | $1M | $1M | $903.0K | $833.0K | $904.0K | $931.0K | $1M | $1M | $1M | $1M | $2M | $2M | $1M | $1M | |
| Operating Cash Flow | $-15M | $-21M | $-17M | $-12M | $-12M | $-15M | $-9M | $-8M | $-8M | $-10M | $-9M | $-7M | $-9M | $-13M | $-5M | $-5M | |
| CapEx | · | · | $24.0K | $4.0K | $22.0K | $44.0K | $0 | $8.0K | · | · | $0 | $37.0K | $2.0K | $6.0K | $6.0K | $83.0K | |
| Investing Cash Flow | $18M | $-15M | $-27M | $-7M | $-48M | $-58M | $22M | $-29M | $3M | $23M | $15M | $6M | $22M | $10M | $-18M | $19M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | $76.0K | · | $27.0K | $0 | $64.0K | $0 | $18.0K | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $-76.0K | · | · | · | $-64.0K | · | · | |
| Financing Cash Flow | $-26.0K | $1M | $81M | $13.0K | $8.0K | $2M | $98M | $0 | $42M | $-76.0K | $0 | $-27.0K | $0 | $-64.0K | $0 | $-18.0K | |
| Free Cash Flow | · | · | · | · | · | $-15M | · | · | · | · | · | · | · | $-13M | · | · |
लाभप्रदता 5
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1575.9% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | -1464.0% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -1575.9% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| ROA | -13.0% | -9.9% | · | -11.1% | -11.6% | -10.1% | · | -12.3% | -9.7% | -12.7% | · | -8.3% | -9.0% | -6.8% | · | -4.7% | |
| ROE | -14.2% | -10.5% | · | -12.4% | -12.7% | -11.0% | · | -14.1% | -10.7% | -14.5% | · | -9.1% | -9.8% | -7.3% | · | -5.0% |
तरलता और शोधन क्षमता 2
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.0 | 15.7 | · | 13.7 | 12.8 | 18.0 | · | 9.8 | 16.3 | 10.5 | · | 11.5 | 17.1 | 14.8 | · | 26.6 | |
| Quick Ratio | 10.7 | 15.2 | · | 13.4 | 12.5 | 17.7 | · | 9.4 | 15.9 | 10.0 | · | 10.9 | 16.3 | 13.5 | · | 26.0 |
दक्षता 1
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
मूल्यांकन (TTM) 8
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-68M | $-58M | · | $-51M | $-48M | $-44M | · | $-42M | $-42M | $-41M | · | $-38M | $-37M | $-36M | · | $-38M | |
| Market Cap | $226M | $287M | · | $168M | $117M | $164M | · | $38M | $24M | $46M | · | $19M | $27M | $35M | · | $33M | |
| P/E | -2.9 | -4.1 | · | -3.0 | -1.9 | -1.9 | · | -0.7 | -0.6 | -1.1 | · | -0.5 | -0.7 | -1.0 | · | -0.9 | |
| P/B | 1.4 | 1.6 | · | 1.3 | 0.8 | 1.0 | · | 0.5 | 0.3 | 0.8 | · | 0.2 | 0.3 | 0.4 | · | 0.2 | |
| P / Tangible Book | 1.4 | 1.6 | · | 1.3 | 0.8 | 1.0 | · | 0.5 | 0.3 | 0.8 | · | 0.2 | 0.3 | 0.4 | · | 0.3 | |
| P / Cash Flow | · | -13.4 | · | · | · | -11.2 | · | · | · | -4.4 | · | · | · | -2.7 | · | · | |
| P / FCF | · | · | · | · | · | -11.1 | · | · | · | · | · | · | · | -2.7 | · | · | |
| Earnings Yield | -34.8% | -24.2% | · | -33.3% | -52.5% | -51.9% | · | -152.5% | -158.2% | -90.8% | · | -200.6% | -135.6% | -102.2% | · | -113.5% |
वित्तीय विवरण आय विवरण, बैलेंस शीट, नकदी प्रवाह — वार्षिक, पिछले 5 वर्ष
आय विवरण
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| शुद्ध आय | $-57M | $-45M | $-40M | $-66M | $-47M |
| तनुकरणित EPS | $-1.34 | $-2.17 | $-3.57 | $-5.86 | $-4.21 |
बैलेंस शीट
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| वर्तमान अनुपात | 14.6 | 15.7 | 11.2 | 15.0 | 21.7 |
| त्वरित अनुपात | 14.2 | 15.5 | 10.7 | 14.7 | 21.2 |
नकदी प्रवाह
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| फ्री कैश फ्लो | $-56M | $-36M | $-38M | $-27M | $-35M |
मेरे मेट्रिक्स आपकी व्यक्तिगत वॉचलिस्ट — पूर्ण फंडामेंटल से चयनित पंक्तियाँ
उन मेट्रिक्स को चुनें जो आपके लिए मायने रखते हैं — ऊपर पूर्ण फंडामेंटल में किसी भी पंक्ति के बगल में ➕ पर क्लिक करें।
आपका चयन सहेजा गया है और यह सभी टिकर में आपके साथ रहता है।
संस्थागत मालिक (13F) 127 फाइलर्स · $162.3M कुल · तिथि अनुसार 30 जून 2026
संस्थान जो अपनी तिमाही SEC फॉर्म 13F में इस स्टॉक को होल्ड करने की रिपोर्ट करते हैं। केवल लॉन्ग पोजीशन; एक ही फाइलर अलग-अलग ऑप्शन लेग्स के लिए दो बार दिखाई दे सकता है। बड़े ऑफसेटिंग पुट/कॉल लेग्स आमतौर पर मार्केट-मेकिंग या हेज्ड इन्वेंट्री को दर्शाते हैं, न कि दिशात्मक विश्वास को।
| नई स्थितियाँ | बाहर निकली पोजीशन | बढ़ाया | घटा हुआ | शुद्ध शेयर परिवर्तन |
|---|---|---|---|---|
| 31 (+4 पिछली तिमाही की तुलना में) | 16 (-5 पिछली तिमाही की तुलना में) | 39 (-8 पिछली तिमाही की तुलना में) | 33 (+10 पिछली तिमाही की तुलना में) | +760K |
Q1 2026 की तुलना में। SEC फॉर्म 13F फाइलिंग तिमाही के अंत के 45 दिनों के भीतर देय होती है, साथ ही देर से फाइल करने वालों के लिए एक छोटा बफर भी होता है — उस विंडो के भीतर आने वाली तिमाहियों को सबसे हालिया पूरी तरह से रिपोर्ट की गई जोड़ी के पक्ष में छोड़ दिया जाता है।
| संस्था | मूल्य | शेयर | % ट्रैक किए गए 13F का | प्रकार |
|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | $27154562 | 5207011 | 16.73% | शेयर |
| MILLENNIUM MANAGEMENT LLC | $11846454 | 3101166 | 7.30% | शेयर |
| Velan Capital Investment Management LP | $10866571 | 2844652 | 6.70% | शेयर |
| VANGUARD CAPITAL MANAGEMENT LLC | $8786508 | 2300133 | 5.41% | शेयर |
| Blackstone Inc. | $8654263 | 2265514 | 5.33% | शेयर |
| ORBIMED ADVISORS LLC | $8480400 | 2220000 | 5.23% | शेयर |
| Sio Capital Management, LLC | $7341551 | 1921872 | 4.52% | शेयर |
| ACORN CAPITAL ADVISORS, LLC | $6693079 | 1752115 | 4.12% | शेयर |
| Integral Health Asset Management, LLC | $5730000 | 1500000 | 3.53% | शेयर |
| 5AM Venture Management, LLC | $5232567 | 1369782 | 3.22% | शेयर |
| GEODE CAPITAL MANAGEMENT, LLC | $4362540 | 1141710 | 2.69% | शेयर |
| STATE STREET CORP | $4080887 | 1068295 | 2.51% | शेयर |
| Qube Research & Technologies Ltd | $3993871 | 1045516 | 2.46% | शेयर |
| Balyasny Asset Management L.P. | $3921960 | 1026691 | 2.42% | शेयर |
| BAKER BROS. ADVISORS LP | $3711565 | 971614 | 2.29% | शेयर |
| ADAR1 Capital Management, LLC | $3592756 | 940512 | 2.21% | शेयर |
| CITADEL ADVISORS LLC | $3414045 | 893729 | 2.10% | शेयर |
| BANK OF AMERICA CORP /DE/ | $3287679 | 860649 | 2.03% | शेयर |
| DIMENSIONAL FUND ADVISORS LP | $2389918 | 625633 | 1.47% | शेयर |
| Point72 Asset Management, L.P. | $2096920 | 548932 | 1.29% | शेयर |
| Catalio Capital Management, LP | $1986965 | 520148 | 1.22% | शेयर |
| GOLDMAN SACHS GROUP INC | $1936106 | 506834 | 1.19% | शेयर |
| Walleye Capital LLC | $1930750 | 505432 | 1.19% | शेयर |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1878130 | 491657 | 1.16% | शेयर |
| MORGAN STANLEY | $1833917 | 480083 | 1.13% | शेयर |
| UBS Group AG | $1723538 | 451188 | 1.06% | शेयर |
| VANGUARD FIDUCIARY TRUST CO | $1278489 | 334683 | 0.79% | शेयर |
| Verdad Advisers, LP | $1192791 | 312249 | 0.73% | शेयर |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $1129058 | 295565 | 0.70% | शेयर |
| RENAISSANCE TECHNOLOGIES LLC | $960730 | 251500 | 0.59% | शेयर |
| OPPENHEIMER & CO INC | $910543 | 238362 | 0.56% | शेयर |
| Jump Financial, LLC | $775842 | 203100 | 0.48% | शेयर |
| CIBC WORLD MARKET INC. | $636011 | 166495 | 0.39% | शेयर |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $603449 | 157971 | 0.37% | शेयर |
| J. Goldman & Co LP | $515700 | 135000 | 0.32% | शेयर |
| SUPERSTRING CAPITAL MANAGEMENT LP | $463966 | 121457 | 0.29% | शेयर |
| Fisher Asset Management, LLC | $380342 | 99566 | 0.23% | शेयर |
| AMERICAN CENTURY COMPANIES INC | $376220 | 98487 | 0.23% | शेयर |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $325961 | 85330 | 0.20% | शेयर |
| TWO SIGMA INVESTMENTS, LP | $266071 | 69652 | 0.16% | शेयर |
| FMR LLC | $260012 | 68066 | 0.16% | शेयर |
| XTX Topco Ltd | $244281 | 63948 | 0.15% | शेयर |
| RHUMBLINE ADVISERS | $241589 | 63245 | 0.15% | शेयर |
| TRUIST FINANCIAL CORP | $229200 | 60000 | 0.14% | शेयर |
| Assenagon Asset Management S.A. | $229024 | 59954 | 0.14% | शेयर |
| Trexquant Investment LP | $227733 | 59616 | 0.14% | शेयर |
| DEUTSCHE BANK AG\ | $220464 | 57713 | 0.14% | शेयर |
| ALPS ADVISORS INC | $217897 | 57041 | 0.13% | शेयर |
| AMERIPRISE FINANCIAL INC | $214863 | 56247 | 0.13% | शेयर |
| PRUDENTIAL FINANCIAL INC | $193789 | 50730 | 0.12% | शेयर |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | $191000 | 50000 | 0.12% | शेयर |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $154252 | 40380 | 0.10% | शेयर |
| Alyeska Investment Group, L.P. | $151753 | 39726 | 0.09% | शेयर |
| Quadrature Capital Ltd | $150199 | 39319 | 0.09% | शेयर |
| Marex Group Ltd | $134655 | 35250 | 0.08% | शेयर |
| WINTON GROUP Ltd | $125296 | 32800 | 0.08% | शेयर |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $113454 | 29700 | 0.07% | शेयर |
| MetLife Investment Management, LLC | $108404 | 28378 | 0.07% | शेयर |
| MARSHALL WACE, LLP | $106995 | 28009 | 0.07% | शेयर |
| ALLIANCEBERNSTEIN L.P. | $93988 | 18040 | 0.06% | शेयर |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $92043 | 24095 | 0.06% | शेयर |
| WOLVERINE TRADING, LLC | $88200 | 20000 | 0.05% | पुट ऑप्शन |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $87478 | 22900 | 0.05% | पुट ऑप्शन |
| CITIGROUP INC | $80698 | 21125 | 0.05% | शेयर |
| Jain Global LLC | $80220 | 21000 | 0.05% | शेयर |
| Invesco Ltd. | $78295 | 20496 | 0.05% | शेयर |
| Vanguard Global Advisers, LLC | $76885 | 20127 | 0.05% | शेयर |
| PRELUDE CAPITAL MANAGEMENT, LLC | $74922 | 19613 | 0.05% | शेयर |
| EntryPoint Capital, LLC | $73673 | 19286 | 0.05% | शेयर |
| LPL Financial LLC | $73077 | 19130 | 0.05% | शेयर |
| VANGUARD GROUP INC | $70479 | 13223 | 0.04% | शेयर |
| Squarepoint Ops LLC | $69234 | 18124 | 0.04% | शेयर |
| IEQ CAPITAL, LLC | $68489 | 17929 | 0.04% | शेयर |
| Police & Firemen's Retirement System of New Jersey | $67114 | 17569 | 0.04% | शेयर |
| BARCLAYS PLC | $60665 | 15881 | 0.04% | शेयर |
| BlackRock, Inc. | $58950 | 15432 | 0.04% | शेयर |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $56834 | 14878 | 0.04% | शेयर |
| INTECH INVESTMENT MANAGEMENT LLC | $51807 | 13562 | 0.03% | शेयर |
| WOLVERINE TRADING, LLC | $51315 | 11636 | 0.03% | शेयर |
| Mariner, LLC | $45441 | 11899 | 0.03% | शेयर |
| Bank of New York Mellon Corp | $43877 | 11486 | 0.03% | शेयर |
| VOYA INVESTMENT MANAGEMENT LLC | $43812 | 11469 | 0.03% | शेयर |
| D. E. Shaw & Co., Inc. | $42452 | 11113 | 0.03% | शेयर |
| COMMONWEALTH EQUITY SERVICES, LLC | $42020 | 11000 | 0.03% | शेयर |
| WELLS FARGO & COMPANY/MN | $41161 | 10775 | 0.03% | शेयर |
| Essential Partners LLC | $37444 | 9802 | 0.02% | शेयर |
| MERCER GLOBAL ADVISORS INC /ADV | $34525 | 9038 | 0.02% | शेयर |
| NORTHERN TRUST CORP | $32061 | 8393 | 0.02% | शेयर |
| CWM, LLC | $30458 | 5846 | 0.02% | शेयर |
| NEW YORK STATE COMMON RETIREMENT FUND | $30178 | 7900 | 0.02% | शेयर |
| BNP PARIBAS FINANCIAL MARKETS | $28788 | 7536 | 0.02% | शेयर |
| Tower Research Capital LLC (TRC) | $19062 | 4990 | 0.01% | शेयर |
| Legal & General Group Plc | $17129 | 4490 | 0.01% | शेयर |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $14645 | 2811 | 0.01% | शेयर |
| Ameritas Investment Partners, Inc. | $12598 | 3298 | 0.01% | शेयर |
| Nuveen, LLC | $9642 | 2524 | 0.01% | शेयर |
| Integrated Wealth Concepts LLC | $6684 | 1750 | 0.00% | शेयर |
| Arax Advisory Partners | $6383 | 1671 | 0.00% | शेयर |
| Russell Investments Group, Ltd. | $6085 | 1593 | 0.00% | शेयर |
| ROYAL BANK OF CANADA | $6000 | 1577 | 0.00% | शेयर |
कंपनी के अंदरूनी सूत्र 40 इनसाइडर्स · 16 अधिकारी · 20 निदेशक
| अंदरूनी | भूमिका | अंतिम गतिविधि | शेयरों का स्वामित्व | खरीद 12m | बिक्री 12m | नेट 12m |
|---|---|---|---|---|---|---|
| Jesse Shefferman | CEO and President | 29 जून 2026 M | 691832 | 0 | 1 | $-882160 |
| Timothy P Noyes | President and CEO | 31 जनवरी 2019 A | 0 | 0 | 0 | $0 |
| Patrick Fabbio | Chief Financial Officer | 26 जनवरी 2026 F | 64115 | 0 | 0 | $0 |
| Blaine Davis | Chief Financial Officer | 15 जुलाई 2022 F | 20662 | 0 | 0 | $0 |
| George Arthur Eldridge, | Sr VP, CFO, Treasr, Asst Secy | 18 जनवरी 2019 A | 29132 | 0 | 0 | $0 |
| William Conkling | Chief Commercial Officer | 2 जून 2026 F | 69992 | 0 | 0 | $0 |
| Jacqueline Zummo | Chief R&D Officer | 8 अप्रैल 2026 S | 94827 | 0 | 2 | $-124989 |
| Hannah Fry | VP, Controller | 26 जनवरी 2026 F | 42723 | 0 | 0 | $0 |
| Leonardo Viana Nicacio | Chief Medical Officer | 16 जनवरी 2026 A | 78181 | 0 | 0 | $0 |
| Jathin Bandari | Chief Medical Officer | 19 जनवरी 2024 A | 56704 | 0 | 0 | $0 |
| Julio Casoy | Chief Medical Officer | 9 जनवरी 2020 A | 45500 | 0 | 0 | $0 |
| Steven Keith Burke | SVP and Chief Medical Officer | 15 मार्च 2019 G | 26332 | 0 | 0 | $0 |
| Bradley J Hartman | VP, People | 18 जनवरी 2019 A | — | 0 | 0 | $0 |
| Matthew Paul Kowalsky | VP, Legal and Secretary | 18 जनवरी 2019 A | 29479 | 0 | 0 | $0 |
| Scott E. Toner | Senior VP of Commercial | 18 जनवरी 2019 A | 23357 | 0 | 0 | $0 |
| Gottlieb Daniel Philip | VP Corporate Development | 18 जनवरी 2019 A | 244 | 0 | 0 | $0 |
| Michael Edward Solomon | निदेशक | 15 जून 2026 A | 26500 | 0 | 0 | $0 |
| Jane Huang | निदेशक | 15 जून 2026 A | — | 0 | 0 | $0 |
| Barry P Flannelly | निदेशक | 15 जून 2026 A | — | 0 | 0 | $0 |
| Cynthia Smith | निदेशक | 15 जून 2026 A | — | 0 | 0 | $0 |
| Richard S Levy | निदेशक | 15 जून 2026 A | 51000 | 0 | 0 | $0 |
| Roger Garceau | निदेशक | 15 जून 2026 A | 33000 | 0 | 0 | $0 |
| Gregory Sargen | निदेशक | 15 जून 2026 A | 31000 | 0 | 0 | $0 |
| Luke M Beshar | निदेशक | 15 जून 2026 A | 198000 | 0 | 0 | $0 |
| Scott Braunstein | निदेशक | 9 जून 2020 A | 26500 | 0 | 0 | $0 |
| John Gordon Freund | निदेशक | 8 नवमबर 2019 C | 2175882 | 0 | 0 | $0 |
| Hubert Birner | निदेशक | 8 जून 2018 A | 1943059 | 0 | 0 | $0 |
| Paul J Hastings | निदेशक | 8 जून 2018 A | — | 0 | 0 | $0 |
| Scott A Canute | निदेशक | 8 जून 2018 A | — | 0 | 0 | $0 |
| Garen G Bohlin | निदेशक | 8 जून 2018 A | 53312 | 0 | 0 | $0 |
| Jonathan S Leff | निदेशक | 8 जून 2018 A | — | 0 | 0 | $0 |
| Brendan O'Leary | निदेशक | 9 जून 2016 A | 1387198 | 0 | 0 | $0 |
| Dmitry Kobyzev | निदेशक | 2 जून 2015 A | 1165344 | 0 | 0 | $0 |
| Gregory D Phelps | निदेशक | 2 जून 2015 A | — | 0 | 0 | $0 |
| Opaleye, L.P. | 10% मालिक | 9 जनवरी 2020 A | 2208472 | 0 | 0 | $0 |
| Martin Sebastian Olivo | — | 10 जून 2021 P | 14344 | 0 | 0 | $0 |
| Randall Marshall | — | 14 सितमबर 2020 S | 585600 | 0 | 0 | $0 |
| Timothy Haines | — | 12 नवमबर 2019 C | 2144517 | 0 | 0 | $0 |
| Abingworth LLP | — | 12 नवमबर 2019 C | 2144517 | 0 | 0 | $0 |
| Stuart A Kingsley | — | 8 जून 2018 A | — | 0 | 0 | $0 |
SEC फॉर्म 3/4/5 फाइलिंग से अंदरूनी सूत्र; नेट = केवल ओपन-मार्केट P/S
कार्यकर्ता और 5%+ मालिक 8 होल्डिंग्स
जिन निवेशकों ने SEC शेड्यूल 13D दाखिल किया है — जारीकर्ता को प्रभावित करने के इरादे से 5% से अधिक लाभकारी स्वामित्व (कार्यकर्ता दांव, बोर्ड अभियान, M&A)। प्रत्येक पंक्ति उस फाइलर की स्थिति की सबसे हालिया ज्ञात स्थिति दिखाती है।
| फाइलर | दाखिल किया | दांव | स्थिति | उद्देश्य | फाइलिंग |
|---|---|---|---|---|---|
| Deerfield Partners, L.P., Deerfield Private Design Fund III, L.P., Deerfield Private Design Fund IV, L.P., Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Management Company, L.P., James E. Flynn | 8 जनवरी 2021 | — | प्रारंभिक फाइलिंग | — | SEC |
| Opaleye Management Inc., Opaleye, L.P., James Silverman ×3 फाइलिंग | 25 सितमबर 2020 | — | प्रारंभिक फाइलिंग | — | SEC |
| Deerfield Special Situations Fund, L.P., Deerfield Partners, L.P., Deerfield Private Design Fund III, L.P., Deerfield Private Design Fund IV, L.P., Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Management Company, L.P., James E. Flynn ×6 फाइलिंग | 17 जनवरी 2020 | — | प्रारंभिक फाइलिंग | — | SEC |
| Abingworth LLP, Abingworth Bioventures VI, LP | 17 जनवरी 2020 | — | प्रारंभिक फाइलिंग | M&A / बिक्री | SEC |
| Abingworth LLP 98-051-8585, Abingworth Bioventures VI, LP 98-040-3543 ×3 फाइलिंग | 14 नवमबर 2019 | — | प्रारंभिक फाइलिंग | बोर्ड अभियान | SEC |
| TVM Life Science Ventures VI L.P., TVM Life Science Ventures VI GmbH & Co. KG, TVM Life Science Ventures Management VI L.P., Hubert Birner, Stefan Fischer, Helmut Schuehsler ×2 फाइलिंग | 2 अगस्त 2017 | — | प्रारंभिक फाइलिंग | निष्क्रिय निवेश | SEC |
| Deerfield Mgmt, L.P., Deerfield Management Company, L.P., Deerfield Mgmt III, L.P., Deerfield Special Situations Fund, L.P., Deerfield Partners, L.P., Deerfield International Master Fund, L.P., Deerfield Private Design Fund III, L.P., James E. Flynn | 29 जून 2017 | — | प्रारंभिक फाइलिंग | निष्क्रिय निवेश | SEC |
| Skyline Venture Partners Qualified Purchaser Fund IV, L.P., Skyline Venture Management IV, LLC, John G. Freund, Yasunori Kaneko | 3 नवमबर 2014 | — | प्रारंभिक फाइलिंग | निष्क्रिय निवेश | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ईटीएफ स्वामित्व 22 ETFs द्वारा धारित
वजन केवल प्रत्यक्ष इक्विटी होल्डिंग्स (N-PORT) को दर्शाता है; लीवरेज्ड या डेरिवेटिव-आधारित फंड में अतिरिक्त स्वैप एक्सपोजर हो सकता है जो नहीं दिखाया गया है।
| फंड | भार | इकाइयाँ | तिथि अनुसार | स्रोत |
|---|---|---|---|---|
| SBIO · ALPS ETF Trust | 0.16% | 55748 NS | 31 मई 2026 | N-PORT |
| IWC · iShares Trust | 0.05% | 175831 SH | 8 अगस्त 2026 | दैनिक |
| VFMO · VANGUARD WELLINGTON FUND | 0.03% | 141979 SH | 8 अगस्त 2026 | दैनिक |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.02% | 91844 NS | 31 मई 2026 | N-PORT |
| IWN · iShares Trust | 0.01% | 470658 SH | 8 अगस्त 2026 | दैनिक |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 300912 SH | 8 अगस्त 2026 | दैनिक |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.01% | 45581 SH | 8 अगस्त 2026 | दैनिक |
| RSSL · Global X Funds | 0.01% | 22265 NS | 30 अप्रैल 2026 | N-PORT |
| IWM · iShares Trust | 0.01% | 1336607 SH | 8 अगस्त 2026 | दैनिक |
| DFAS · Dimensional ETF Trust | 0.01% | 179929 NS | 30 अप्रैल 2026 | N-PORT |
| ITWO · ProShares Trust | 0.01% | 2419 NS | 31 मई 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.01% | 3715 NS | 30 अप्रैल 2026 | N-PORT |
| UWM · ProShares Trust | 0.00% | 1891 NS | 31 मई 2026 | N-PORT |
| URTY · ProShares Trust | 0.00% | 1912 NS | 31 मई 2026 | N-PORT |
| HDG · ProShares Trust | 0.00% | 48 NS | 31 मई 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 5791 NS | 30 अप्रैल 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 18477 NS | 30 अप्रैल 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 7914 NS | 30 अप्रैल 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 20174 NS | 30 अप्रैल 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 586965 SH | 8 अगस्त 2026 | दैनिक |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 1657879 SH | 8 अगस्त 2026 | दैनिक |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 3185 SH | 8 अगस्त 2026 | दैनिक |